Kura Oncology (KURA) Treasury Shares (2014 - 2026)

Kura Oncology (KURA) reported Treasury Shares of $436667.0 for Q1 2026, little changed on a QoQ basis from $436667.0 in Q4 2025.

Kura Oncology (KURA) has 6 years of Treasury Shares data on file, last reported at $436667.0 in Q1 2026.

  • Quarterly Treasury Shares changed N/A year-over-year to $436667.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $436667.0 (changed N/A YoY) and the FY2025 annual result came in at $436667.0, changed N/A from the prior year.
  • Treasury Shares held at $436667.0 in Q1 2026 per KURA's latest filing, from $436667.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $775534.0 in Q3 2025 and bottomed at $436667.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 265,401.92
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 700,000.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 34.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Kura Oncology 801.92 Mn 801.92 Mn 18.00 Mn 436,667.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 436,667.00
Mar 31, 2026 436,667.00
Dec 31, 2025 436,667.00
Dec 31, 2025 436,667.00
Sep 30, 2025 775,534.00
Sep 30, 2025 775,534.00
Dec 31, 2017 793,000.00
Dec 31, 2017 793,000.00
Dec 31, 2016 1.70 Mn
Dec 31, 2016 1.70 Mn
Dec 31, 2015 516,000.00
Dec 31, 2015 516,000.00
Sep 30, 2015 3.57 Mn
Sep 30, 2015 3.57 Mn
Jun 30, 2015 3.90 Mn
Jun 30, 2015 3.90 Mn
Mar 31, 2015 4,191.00
Mar 31, 2015 4,191.00
Dec 31, 2014 4.53 Mn
Dec 31, 2014 4.53 Mn